Hyaluronan (HA) is an acidic high molecular weight cell surface polysaccharide ubiquitously expressed by vertebrates, some pathogenic bacteria and even viruses. HA modulates many essential physiological processes and is implicated in numerous pathological conditions ranging from autoimmune diseases to cancer. In various pathogens, HA functions as a non-immunogenic surface polymer that reduces host immune responses. It is a linear polymer of strictly alternating glucuronic acid and N-acetylglucosamine units synthesized by HA synthase (HAS), a membrane-embedded family-2 glycosyltransferase. The enzyme synthesizes HA and secretes the polymer through a channel formed by its own membrane-integrated domain. To reveal how HAS achieves these tasks, we determined the biologically functional units of bacterial and viral HAS in a lipid bilayer environment by co-immunoprecipitation, single molecule fluorescence photobleaching, and site-specific crosslinking analyses. Our results demonstrate that bacterial HAS functions as an obligate homo-dimer with two functional HAS copies required for catalytic activity. In contrast, the viral enzyme, closely related to vertebrate HAS, functions as a monomer. Using site-specific cross-linking, we identify the dimer interface of bacterial HAS and show that the enzyme uses a reaction mechanism distinct from viral HAS that necessitates a dimeric assembly.
Introduction
Hyaluronan (HA) is an abundant extracellular glycosaminoglycan that is ubiquitously expressed in vertebrates (Girish and Kemparaju 2007) . It is a linear polysaccharide composed of alternating glucuronic acid (GA) and N-acetylglucosamine (GlcNAc) units that is particularly enriched in the extracellular matrix (ECM) of connective tissues, the synovial fluid in joints and the vitreous humor of the eye (Girish and Kemparaju 2007; Weigel and DeAngelis 2007) . HA is essential for embryological development (Camenisch et al. 2000; Roughley et al. 2011) . It modulates many physiological processes, including embryogenesis, cell migration and adhesion, wound healing and angiogenesis, among many others (Girish and Kemparaju 2007) . Altered, often elevated, expression levels of HA correlate with numerous pathological conditions, for example malignant transformations, autoimmune diseases, chronic inflammations and infertility (Toole and Slomiany 2008; Tian et al. 2013; Singleton 2014) .
In most species, HA is synthesized by a membrane-integrated processive glycosyltransferase (GT), the HA synthase (HAS) (Weigel and Deangelis 2007; Bi et al. 2015) . Vertebrates express three different HAS isoforms and co-immuno-precipitation and FRET analyses suggest the presence of homo-and hetero-oligomers in vivo, albeit of unknown biological function (Karousou et al. 2010; Bart et al. 2015) . While HAS-1 and HAS-3 are non-essential, HAS-2 is required and knockout mice are embryonic lethal, succumbing at midgestation (Camenisch et al. 2000) . The enzyme contains six predicted transmembrane (TM) helices, two N-terminal and four C-terminal of the GT domain, and is sufficient to synthesize HA from UDP-activated GA and GlcNAc, as well as to translocate the polymer across the plasma membrane (Hubbard et al. 2012; Bi et al. 2015) . The mechanism by which HAS combines these tasks is currently unknown.
Bacteria and viruses provide additional model systems for HA biosynthesis. Bacteria produce HA primarily as a non-immunogenic and highly hydrated extracellular capsule via two fundamentally different pathways (Sugahara et al. 1979; Kumari and Weigel 1997) . In Gram-negatives (first identified in Pasteurella multocida), HA is synthesized as a lipid-anchored polymer by a membrane-associated, non-processive GT (Carter and Annau 1953; DeAngelis et al. 1998; DeAngelis 1999) . The assembled polymer is secreted across the inner and the outer bacterial membrane by an ABC transporter, partnering with periplasmic and outer membrane components (Whitfield 2006) .
In Gram-positives, including various Streptococcus and Bacillus strains, HA is synthesized by a membrane-integrated GT similar to vertebrate HAS, which also translocates HA during synthesis (Weigel and Deangelis 2007; Hubbard et al. 2012) . Bacterial HASs contain four predicted TM helices that frame the cytosolic GT domain (Heldermon et al. 2001) .
In addition, some algal viruses, including the Chlorella virus (Cv), also express HASs that are highly homologous to the vertebrate enzymes. Viral and vertebrate HASs share a high degree of sequence identity and a similar TM topology containing two TM helices N-terminal and 4 C-terminal to the GT domain (DeAngelis et al. 1997) .
Processive family-2 GTs, such as cellulose, chitin, hyaluronan and alginate synthases, transfer nucleotide-activated sugars (the donor) to the nascent polysaccharide (acceptor) without releasing the polysaccharide product after each elongation cycle (Bi et al. 2015) . The enzymes share several sequence motifs required for donor and acceptor binding as well as polysaccharide translocation. All family members contain a QxxRW motif, of which the Trp residue stabilizes the acceptor sugar (Saxena and Brown 1997; Morgan et al. 2013) .
Analyses of cellulose synthase provided important insights into the reaction mechanism of family-2 GTs. Cellulose synthase attaches new glucose units to the non-reducing end of the nascent cellulose polymer, using UDP-glucose as donor (Koyama et al. 1997) . After each elongation step, the extended cellulose polymer is translocated into the enzyme's TM channel in preparation for another elongation cycle (McNamara et al. 2015; Morgan et al. 2016) . In contrast, the mechanism by which HAS synthesizes and translocates HA is less well understood. Not only does the enzyme recognize two different substrates (UDP-GA and UDP-GlcNAc), it also polymerizes the donor sugars in a strictly alternating fashion and forms two different glycosidic linkages: a ß(1→4) between GlcNAc and GA, followed by a ß(1→3) between GA and GlcNAc (Weigel and Deangelis 2007) .
Several reports suggest that bacterial and vertebrate HASs synthesize HA by different mechanisms. Previous studies on Streptococcus equisimilis (Se) HAS showed that the enzyme elongates the reducing end of the polymer (Tlapak-Simmons et al. Prehm 2006 ), whereas studies on Xenopus laevis (Xl) HAS indicate a non-reducing end polymerization similar to cellulose and chitin synthases (Bodevin-Authelet et al. 2005) . To gain structural and functional insights into the HA biosynthesis mechanism in bacteria, viruses and vertebrates, we determined the biologically functional unit of Se-and Cv-HAS in lipid bilayer environments and compared HA biosynthesis between Se-, Cv-and Xl-HAS. Our results show that membrane-integrated bacterial HAS dimerizes with two protomers forming a single active complex. Site-directed crosslinking localizes the dimer interface near the second TM helix. Further, bacterial HAS elongates the polymer's reducing end, which is covalently attached to a UDP moiety. In contrast, viral HAS is monomeric and elongates the non-reducing end of HA. Combined, our results document convergent evolutionary processes of HA biosynthesis across different kingdoms of life.
Results

Lipid membranes stabilize HAS's catalytic activity
Streptococcal equisimilis HAS is well expressed in E. coli and robustly synthesizes HA both in vivo and in vitro (Tlapak-Simmons et al. 2004; Yu and Stephanopoulos 2008) . Se-HAS requires the substrates UDP-GA and -GlcNAc to initiate HA biosynthesis and produces high molecular weight HA in the mega-Dalton size range (DeAngelis et al. 1993; Tlapak-Simmons et al. 1999 , 2004 . Lipid vesicles (IMVs) containing Se-HAS synthesize HA only in the presence of both substrates and the generated polymer is readily degraded by hyaluronidase ( Figure S1 ). However, we observed that this catalytic activity is almost completely lost after solubilizing the IMVs in non-denaturing detergents ( Figure 1A) . Among the different detergents tested, only dodecyl-β-D-maltopyranoside (DDM) and digitonin supported significant HA-biosynthetic activity in surfo ( Figure 1A ). Yet, detergent-inactivation is reversible; reforming lipid vesicles from "inactive" membrane extracts restores catalytic activity in some cases ( Figure 1A ). Similar results were obtained previously when Se-HAS was purified in a catalytically inactive state in the detergent LysoFosCholine Ether 14 (LFCE14) but exhibited robust HA biosynthetic activity upon reconstitution into E. coli total lipid extract proteoliposomes (PL) (Hubbard et al. 2012) .
Similarly, detergent solubilization of Cv-HAS also led to rapid inactivation of the enzyme. The catalytic activity was only restored from DDM-solubilized Cv-HAS upon reconstitution into PL ( Figures 1B and S2) . Notably, both Se-and Cv-HAS maintained catalytic activity in digitonin. These data indicate that HAS is particularly sensitive to delipidation, yet inactivation can be reversed under certain solubilization conditions. Possible explanations for this rapid inactivation are discussed below.
Bacterial but not viral HAS oligomerizes in biological membranes
The sensitivity of HAS to delipidation could be due to conformational changes of the enzyme during solubilization and/or disruption of quaternary structures required for activity. We performed co-purification studies with differently tagged HAS species to test whether catalytically active bacterial or viral HAS form oligomers, as recently observed for mouse HASs (Karousou et al. 2010) . To this end, IMVs containing co-expressed poly-His-and FLAG-tagged HAS constructs were solubilized in digitonin, which maintains catalytic activity of both HAS species (Figure 1 ) and the enzymes were affinity purified.
Purification by immobilizing Se-HAS via either its poly-His or FLAG tag resulted in co-purification of the other species, suggesting a direct interaction between Se-HAS protomers ( Figure 2A ). Additionally, tandem purification by first employing a poly-His binding resin followed by anti-FLAG agarose isolated catalytically active Se-HAS complexes immuno-reactive to both anti-His and anti-FLAG antibodies ( Figure 2B and C).
Se-HAS expression in E. coli results in the accumulation of HA in the growth medium, suggesting that the enzyme is catalytically active already in the expression host (Yu and Stephanopoulos 2008) . Because HA polymers have been shown to interact and form hydrated meshworks in solution (Scott et al. 1991; Scott and Heatley 1999) , we sought to exclude the possibility that HASassociated HA promotes the observed co-purification of Se-HAS species. Therefore, we co-purified wild type (WT) and catalytically inactive Se-HAS carrying FLAG-and His-tags, respectively. Inactive Se-HAS was generated by replacing Asp260 with Asn, which belongs to a conserved GDD motif and likely forms the general base required for glycosyl transfer (Bi et al. 2015) . Accordingly, introducing Asn at position 260 (D260N) renders the enzyme catalytically inactive without affecting its expression levels ( Figure S1 ). Coexpression and tandem purification of wild type and D260N Se-HAS demonstrated that the catalytically inactive enzyme interacts with the wild type copy, suggesting that complex formation is independent of catalysis ( Figure 2D and E). Importantly, the catalytic activity of the tandem purified complex is lost after the second affinity purification step when only complexes containing both wild type and inactive enzymes are present ( Figure 2F ). Further, two catalytically inactive Se-HAS copies also co-purify, excluding that complex formation is mediated by HA ( Figure 2G ). Figure 2F suggests that Se-HAS complexes containing both wildtype and inactive copies are catalytically inactive, supporting a model in which a functional Se-HAS is formed from at least two catalytically active protomers. To test this hypothesis, we individually purified WT and D260N Se-HAS in LFCE14 detergent, which stabilizes Se-HAS monomers (Hubbard et al. 2012 ) and co-reconstituted the enzymes at a constant WT and increasing D260N concentrations. Indeed, in vitro HA biosynthesis rapidly declines with increasing D260N concentrations, suggesting that mixed WT/D260N complexes are catalytically inactive ( Figure 2H ).
To investigate whether viral HAS also forms homo-oligomers, we co-expressed His-and FLAG-tagged Cv-HAS in E. coli and performed similar co-purification experiments in a digitonin-solubilized state. Contrary to the bacterial enzyme, FLAG-tagged Cv-HAS does not co-purify with the His-tagged species, although both versions are well expressed and the purified enzyme is catalytically active ( Figure 2I and J).
Bacterial HAS assembles into homo-dimers
Our co-purification experiments are consistent with oligomerization of Se-HAS but provide little stoichiometric information on the complex. To determine the accurate quaternary structure of Se-HAS, we employed single-molecule photobleaching experiments (Ulbrich and Isacoff 2007) . By attaching one fluorescent label to each protomer, any oligomeric complex formed will have a stoichiometry equal to that of the fluorophore. Then, the number of fluorophores in each complex can be determined by counting the bleaching steps during a time series of images of labeled complexes at high dilution in a supported planar bilayer.
We fused Se-HAS N-terminally to a SNAP-tag, a small domain of the O 6 -alkylguanine-DNA alkyltransferase that covalently interacts with benzylguanine derivatives (Kolberg et al. 2013) . Upon purification in the detergent LFCE14 and reconstitution into dioleoyl-phosphatidylcholine (DOPC) liposomes, SNAP-tagged Se-HAS is catalytically active, demonstrating that the SNAP domain does not interfere with function ( Figure S3 ). Following purification by metal affinity chromatography, SNAP-Se-HAS was fluorescently labeled by incubation with an excess of AlexaFluor647-conjugated substrate and further purified by gel filtration chromatography. Protein and fluorophore absorbance measurements indicated that 97-99% of SNAP-tagged Se-HAS was fluorescently labeled across multiple protein preparations.
Labeled SNAP-Se-HAS was reconstituted into liposomes at a 1:10 6 -10 8 protein to lipid molar ratio and the vesicles were fused with a lipid monolayer prepared on a quartz cover-slide to generate a supported planar bilayer for TIRF microscopy (Kalb et al. 1992 ).
In agreement with our co-purification results, SNAP-Se-HAS particles bleached primarily in two steps, with minor fractions bleaching in one and three steps ( Figure 3A and B). Across all particles analyzed (>5000 for all experiments), the initial particle fluorescence intensities and bleaching steps were consistent in magnitude.
The distribution of bleaching steps did not change in the presence of the substrate UDP-GA ( Figure 3B ), suggesting that substrate binding does not alter the oligomeric state of Se-HAS. However, coreconstituting an equimolar ratio of labeled and unlabeled SNAP-Se-HAS resulted in primarily monophasic bleaching, consistent with mixed Se-HAS dimers containing fluorescent and nonfluorescent copies ( Figure 3C ). Considering the high lipid-to-protein molar ratio in the generated membranes (1:10 6 -10 8 ) and the robust two-step bleaching profile observed, suggests that Se-HAS forms stable dimers in a lipid environment, which do not dissociate under the experimental conditions.
In agreement with our co-purification data, the catalytically inactive D260N mutant also exhibited a two-step bleaching distribution in the absence and the presence of substrate ( Figure 3D ), further confirming that dimerization is driven by Se-HAS interactions and not the synthesis of or association with HA.
We also analyzed the quaternary structure of viral HAS by singlemolecule photobleaching. Using a similar labeling approach ( Figure S3 ), SNAP-Cv-HAS was analyzed under identical conditions to SNAP-Se-HAS, yet exhibited a monophasic bleaching distribution, both in the presence and the absence of the UDP-GA substrate (Figure 3E and F) . Taken together, our data reveal that bacterial HAS dimerizes in a lipid bilayer environment, whereas viral HAS, which closely resembles the vertebrate orthologs, remains monomeric.
Biologically functional enzymes are formed by monomeric viral and dimeric bacterial HASs
We next asked whether HA biosynthesis alters the oligomeric state of HAS. To this end, fluorescently labeled HAS was reconstituted into liposomes and HA biosynthesis was initiated upon incubation with substrates. The HA synthesizing vesicles were then fused with a lipid monolayer to produce supported planar bilayers containing HAS bound to a nascent HA chain. HA was specifically detected with biotinylated bovine HA-binding protein (HABP) coupled to Co-purification of co-expressed His-and FLAG-tagged Se-HAS using Ni-NTA (left) and FLAG-agarose (right), shown as western blots against the affinity tags. Sol: Detergent-solubilized material; W, E: Wash and elution buffers. (B) Tandem purification of His-and FLAG-tagged Se-HAS. The material eluted from Ni-NTA was purified using FLAG-agarose. (C) Catalytic activity of tandem purified Se-HAS. DPM: disintegrations per minute, Error bars represent deviations from the means from at least three independent replicas. (D) As (A) but for co-expressed Histagged wild type (WT) and catalytically inactive (D260N) FLAG-tagged Se-HAS. (E) As (D) but tandem purification of co-expressed WT and D260N Se-HAS. Left panel: Illustration of purification steps. Black and white circles indicate His-and FLAG-tagged WT and D260N Se-HAS, respectively. 1./2. Material recovered after Ni-NTA and FLAG-agarose purification, respectively. (F) Catalytic activity of tandem purified WT and D260N Se-HAS. HA biosynthetic activity was assessed after the first (Ni-NTA) and second (FLAG-agarose) affinity purification. Error bars as in (C). (G) As (D) but tandem purification of His-and FLAG-tagged D260N Se-HAS. (H) Catalytically inactive Se-HAS inhibits activity of WT Se-HAS. Individually purified SNAP-tagged WT and D260N Se-HAS were combined at the indicated molar ratios (WT:D260N) and reconstituted into lipid vesicles. Catalytic activity is expressed relative to the activity in the absence of D260N. Inset: western blot of purified SNAP-tagged WT and D260N Se-HAS. Error bars as in (C). (I) Purification of His-and FLAG-tagged Cv-HAS using FLAG-agarose. Additional bands observed in the 'E' fraction on the α-His blot represent cross-reactive contaminants shedding from the anti-FLAG-agarose beads. (J) Catalytic activity of FLAGagarose purified Cv-HAS. Error bars as in (C). All experiments were performed with digitonin-solubilized protein.
AlexaFluor546-conjugated streptavidin (hereafter referred to as HABP-Strep546) ( Figure 4A ).
HABP-Strep546 labeling is specific for HA. We first tested the binding of HABP-Strep546 to the supported planar bilayer by measuring fluorescence in a TIRF field. The detected HABP-Strep546 signal increases with increasing Se-HAS concentrations in the lipid bilayer and thus Se-HAS-produced HA ( Figure 4B ), and is released upon treatment with hyaluronidase, which specifically degrades the HA polymer ( Figure S4A ). Further, no fluorescent binding was observed with the catalytically inactive D260N mutant or when HABP was omitted in the labeling step ( Figure 4B ), thereby excluding nonspecific streptavidin binding.
To analyze the association of HAS particles with HA, we first determined the number of steps in which fluorescently labeled HAS bleaches (using the described SNAP-tag approach), while at the same time recording its co-localization with the HA-specific HABPStrep546 probe (Figures 4A and S4) . Figure 4C shows that, even under HA biosynthesis conditions, Se-HAS dimers are maintained and about 90% of the observed complexes co-localize with HA. Of the small fraction of observed trimers, only about 55% co-localize with HA, perhaps representing nonspecific interactions. The catalytically inactive D260N mutant, while a dimer, does not co-localize with HA ( Figure 4C ), which confirms the specificity of the HABPStrep546 labeling. Similarly, in the absence of HABP, AlexaFluor546-streptavidin does not associate with Se-HAS, thereby excluding nonspecific interactions with HA or Se-HAS ( Figure 4D ).
By a similar approach, we also determined the oligomeric state of Cv-HAS during HA biosynthesis. In the presence of a nascent HA polymer, Cv-HAS remains monomeric and more than 70% of the monomers are associated with HA ( Figure 4E ). Relative to the resting state of the enzyme ( Figure 3F ), we observe a slight increase in dimeric and trimeric particles, which could be due to interactions of the synthesized HA polymers. As a control, we generated a catalytically inactive Cv-HAS mutant by replacing the N-terminal Asp of the conserved DxD motif with Ala (D201A), thereby preventing nucleotide binding and rendering the enzyme catalytically inactive ( Figure S2 ). As observed for Se-HAS D260N, this inactive mutant does not co-localize with HABP-Strep546, confirming specific binding of HABP to HA ( Figure 4E ). Control labeling experiments in the absence of HABP show negligible background binding of streptavidin to wild type Cv-HAS ( Figure 4F ).
TM helix 2 and the C terminus of Se-HAS sit at the dimer interface Se-HAS dimerization was also detected by chemical cross-linking. We incubated purified and reconstituted Se-HAS in the presence of glutaraldehyde (GluA), which covalently connects primary amines about 8-10 Å apart. GluA readily stabilizes a high molecular weight Se-HAS species migrating near the 100 kDa marker, consistent with a Se-HAS dimer ( Figure S5A ). A significant decrease in the monomeric and increase in dimeric Se-HAS species was observed after a 30 s exposure to 10 mM GluA, prolonged incubations led to a complete loss of the protein band (not shown). Similar experiments with Cv-HAS did not produce a higher molecular weight species, consistent with the single step bleaching of this enzyme ( Figure S5B ).
Next, site-specific cross-linking of Se-HAS was used to gain insights into the dimer architecture. To this end, we introduced the photo-inducible cross-linker para-benzoylphenylalanine (Bpa) at selected sites within the enzyme's TM region (Chin et al. 2002; Ryu and Schultz 2006) . Of the >30 mutants generated, about 24 were catalytically active and selected for cross-linking studies ( Figure S6 ). Exposure of these mutants to ultraviolet light followed by western blotting identified positions generating Se-HAS species twice the molecular weight ( Figure 5A ). These positions clustered in the first predicted periplasmic loop connecting TM helices 1 and 2 (residues 27-30) as well as near the C terminus. To further refine this region, Bpa was introduced at almost every position from residue 29 to 50. UV irradiation of these mutants displays position dependent crosslinking when Bpa replaces Lys31, Leu34, Tyr37, Phe39 or Leu41. No cross-links were observed past Leu41 ( Figure 5A ).
Additional intermolecular cross-linking was apparent at the enzyme's cytosolic C terminus. Replacing Trp410 of the conserved "WGT" motif with Bpa resulted in robust cross-linking in a UV dependent manner ( Figure 5A ). However, this Bpa mutant is catalytically inactive, likely because Bpa replaces an invariant residue ( Figure S6 ). The biological function of the "WGT" motif is currently unknown, yet based on sequence similarity with the "gating loop" of cellulose synthase, its implication in substrate binding has been discussed (Bi et al. 2015) .
The UV-dependent cross-linking of Se-HAS Bpa mutants in IMVs was also reproduced in a chemically defined system. We expressed, purified and reconstituted Se-HAS carrying Bpa instead of Phe28, Lys31, Leu34, Tyr37, Phe39, Leu41, Phe58 or Trp410 ( Figures 5B and S6B) . Except for W410Bpa, all mutants were catalytically active and showed UV-dependent dimer formation ( Figures 5B and S6A) .
Topology predictions of Se-HAS suggest an α-helical conformation of residues 31 through 52, which positions Lys31, Leu34, Tyr37 and Leu41 to one face of the N-terminal half of TM helix 2 ( Figure S6C ). Additional cross-linking of Phe39, which sits on the opposite side of this helix, indicates that TM2 makes multiple interactions with the opposing protomer at the dimer interface.
Se-HAS uses a distinct HA biosynthesis mechanism
We next asked whether the difference in the biologically functional unit of Cv-and Se-HAS reflects different HA biosynthesis mechanisms. As a processive GT, HAS can elongate either the reducing or non-reducing end of the HA polymer. Previous reports provided contradictory results with regard to the direction of HA chain elongation, some suggesting reducing, others non-reducing end elongation (Bodevin-Authelet et al. 2005; Tlapak-Simmons et al. 2005; Prehm 2006) . Recently, mass spectrometry data on Se-HAS-synthesized HA fragments identified UDP-linked oligosaccharides, consistent with a reducing-end elongation mechanism (Weigel et al. 2015 (Weigel et al. , 2017 . In contrast, it has been suggested that vertebrate HAS, homologous to Cv-HAS, elongates the non-reducing end of HA, in agreement with chitin and cellulose biosynthesis (Bodevin-Authelet et al. 2005) . If correct, this would document fundamentally different reaction mechanisms of bacterial and vertebrate HASs.
We first compared the catalytic activities of HA formed by four different enzymes: Se-, Cv-, P. multocida (Pm)-and Xl-HAS. Pm-HAS is a non-processive membrane-associated enzyme that elongates HA at its non-reducing end (DeAngelis 1999) and Xl-HAS corresponds to isoform 1 that shares 32.4% sequence identity with Cv-HAS ( Figure S7 ). All enzymes produced a polysaccharide readily degraded by sheep testicular hyaluronidase, as detected by PAGE and autoradiography of the 14 C-GA-labeled polymer ( Figure 6A ). Hyaluronidase degradation initially accumulated low molecular weight HA oligosaccharides for polymers produced by all species except Pm. These oligosaccharides were further degraded to fragments migrating within the dye front upon prolonged enzymatic degradation, perhaps due to limiting hyaluronidase activity ( Figures 6A and S8A ). Control reactions in the absence of one substrate (UDP-GlcNAc) or upon terminating HA biosynthesis before adding the tracer (UDP-14 C-GA) did not generate a labeled polymer. Strikingly, Se-and Pm-HAS synthesized HA polymers that barely migrated into a 15% polyacrylamide gel, whereas HA produced by Cv-and Xl-HAS separated into broad polymer distributions, resulting in significant smearing ( Figure 6A ). Although we did not determine the exact lengths of the HA polymers formed, the comparison suggests that Cv-and Xl-HAS are less processive in vitro, perhaps due to suboptimal reaction conditions.
Reducing and non-reducing end elongation of polysaccharides follows fundamentally different reaction mechanisms. For reducing end elongation, the substrate (UDP-GA or -GlcNAc) functions as the acceptor, whereas for non-reducing end elongation the acceptor is the nascent polysaccharide. Therefore, polysaccharides elongated at their reducing end are covalently attached to the UDP moiety of the last incorporated sugar, whereas those elongated at the nonreducing end are not. Thus, determining whether the synthesized HA polymers are covalently attached to UDP discriminates the reaction mechanisms.
To detect a covalently attached UDP moiety on HA, we synthesized 14 C-UDP-GA in vitro from 14 C-UDP-glucose by incubation with recombinant UDP-glucose dehydrogenase, which generates 14 C-UDP-GA in an NAD + dependent reaction (Mainprize et al. 2013 ). This tracer contains the 14 C-label on the uracil moiety, thereby enabling detection of UDP-HA polymers by autoradiography. Next, we initiated HA biosynthesis in vitro from liposome-reconstituted HAS, sedimented and washed the vesicles to remove the UDP-GA andGlcNAc substrates, incubated the resuspended vesicles in the presence of 14 C-UDP-GA, and visualized the HA polymers by PAGE and autoradiography. As shown in Figures 6B and S8B , Se-HAS generates a radioactively labeled HA polymer in the presence of 14 C-UDP-GA whereas Cv-HAS does not. Some control repeats showed minor 14 C-UDP-association of Cv-HAS-synthesized HA, perhaps due to nonspecific interactions with HA ( Figure S8C) . Addition of tracer after terminating HA biosynthesis with EDTA significantly reduced the amount of labeled HA; residual labeling likely results from incomplete termination of HA biosynthesis by EDTA ( Figure 6B ).
To further confirm that UDP is indeed covalently attached to the Se-HAS-produced polymer and not trapped in a matrix of high molecular weight HA, Se-HAS-synthesized and 14 C-UDP-labeled HA was treated with hyaluronidase for 5-45 min to produce oligosaccharides, followed by PAGE and autoradiography. Consistent with a covalent UDP modification, the generated fragments were readily detectable by autoradiography and are essentially indistinguishable from 14 C-GA labeled fragments ( Figures 6B and S8B ).
Further, a covalently attached UDP moiety should be removable under alkaline conditions, owing to base-catalyzed intramolecular hydrolysis at the nucleotide's ɑ-phosphate by the C2-hydroxyl of the ribose. Indeed, incubating 14 C-UDP-labeled HA in 0.1 N sodium hydroxide for 15 min significantly reduces the amount of UDPlabeled but not GA-labeled HA ( Figure 6C ). 
Discussion
HA is an important component of the extracellular matrix in vertebrates. The polymer is water-soluble and forms a hydrated gel in aqueous solutions. Owing to its ubiquitous expression in vertebrates, formation of HA capsules by several pathogens is an effective strategy to escape host immune responses. HA is synthesized from intracellular UDP-activated GA and GlcNAc and secreted across the plasma membrane through a channel formed by the TM region of HAS. While the precise HA translocation mechanism is currently unknown, cellulose synthase represents a well-studied homologous enzyme using a molecular ratcheting mechanism for polymer translocation. However, as cellulose synthase elongates the non-reducing end of the polymer, mechanistic parallels can only be drawn if a similar reaction mechanism applies to HAS.
In bacteria, HA biosynthesis by membrane-embedded HAS is confined to Gram-positives. The bacterial synthases share many similarities with, yet are distinct from, their vertebrate counterparts. Most notably, the bacterial enzymes are significantly smaller than the eukaryotic enzymes, containing only 4 instead of 6 TM helices (Heldermon et al. 2001 ). The small number of TM segments makes it unlikely that a single enzyme suffices to form an HA TM channel. Viral HASs provide a convenient model system for vertebrate enzymes because they share the same number of predicted TM helices and an overall high degree of sequence similarity ( Figure S7 ). By using S. equisimilis and Chlorella virus HASs as model systems, we revealed a fundamental difference in quaternary structure between the two species. While viral HAS is monomeric during HA biosynthesis, a dimer of catalytically active HAS forms the functional enzyme in bacteria. This suggests that the predicted 6 TM helices of viral HAS are sufficient to form a HA TM channel, consistent with the architecture of cellulose synthase (Morgan et al. 2013) .
Bacterial HAS, in contrast, dimerizes to be functional and it is likely that the HA channel is formed at the dimer interface. Previous reports using radiation inactivation of Streptococcal HAS suggested the monomer as the biological functional unit (Tlapak-Simmons et al. 1998) . Perhaps the formation of a single mutual TM channel at the HAS dimer interface or the overestimation of the Se-HAS monomer molecular weight explains these discrepancies.
The difference in quaternary structure between bacterial and viral HASs reflects different reaction mechanisms. UDP-labeling of HA produced by bacterial and viral HASs suggests that only the bacterial enzyme elongates HA's reducing end. Viral, and likely also vertebrate, HAS appears to elongate the non-reducing end. Our data is consistent with previous reports on bacterial HA biosynthesis. Here, either the formation of UDP-linked oligosaccharides has been directly confirmed (Weigel et al. 2015 (Weigel et al. , 2017 or reducing end elongation was inferred from differential HA labeling, followed by end-specific enzymatic degradation (Bodevin-Authelet et al. 2005; Tlapak-Simmons et al. 2005; Prehm 2006 ). However, conflicting reports exist for vertebrate HAS, some suggesting reducing while others non-reducing end elongation (Bodevin-Authelet et al. 2005; Prehm 2006 ). Due to the similarities between viral and vertebrate HASs, our data suggest that the vertebrate enzymes also elongate the non-reducing end of HA, consistent with plant and insect cellulose and chitin synthases, respectively.
Homo-and hetero-oligomerization has also been observed for human and mouse HASs in vivo (Karousou et al. 2010; Bart et al. 2015) . Here, oligomerization was detected based on FRET analyses primarily in the perinuclear Golgi region but also in the plasma membrane (PM). This suggests that complex formation could affect trafficking to the PM or activation of the enzyme through post-translational modifications, such as ubiquitination (Karousou et al. 2010) , rather than being required for the basic glycosyl transfer and HA translocation reactions.
Reducing end HA elongation by bacterial HAS explains the requirement for a stable dimeric assembly. Because the reducing end-elongated polymer is covalently attached to UDP, bacterial HAS must concurrently bind both the UDP moiety of the polymer as well as the UDP-activated substrate molecule. The loop region between TM helices 2 and 3 of Se-HAS forms an intracellular GT domain, which, based on conserved signature motifs, binds a single UDP moiety (Charnock and Davies 1999; Lairson et al. 2008; Morgan et al. 2013) . Thus, chain elongation by Se-HAS requires simultaneous substrate and polymer binding, which can be accomplished by two GT domains in close proximity (Figure 7 ). During biosynthesis, the UDP-moiety of the nascent polymer likely alternates between the protomers' active sites. This model explains why only dimers of two WT copies are catalytically active; each protomer must function either in substrate binding and activation of the nucleophile or in polymer binding (Figure 7 ). For non-reducing end elongation by monomeric HAS, a cycle of substrate binding, glycosyl transfer, UDP release and polymer translocation suffices to explain HA biosynthesis, as recently delineated for cellulose synthase (McNamara et al. 2015) .
Further, the UDP moiety attached to Se-HAS-synthesized HA may function as a roadblock that prevents slippage and premature termination of HA biosynthesis. Accordingly, Se-HAS appears to be significantly more processive compared to Xl-and Cv-HAS in vitro, as it forms essentially only high molecular weight polymers, compared to the broad HA size distributions synthesized by the other enzymes ( Figure 6A ).
How HAS adheres to a strictly alternating GlcNAc-GA sequence is currently unknown. It is possible that the newly incorporated sugar alters the specificity of the substrate binding pocket, such that Fig. 7 . Model of HA biosynthesis by dimeric and monomeric HASs. Dimeric bacterial HAS forms a single HA TM channel that is associated with two GT domains. Elongation at the reducing end generates a UDP-linked polymer bound to one GT domain. The last incorporated sugar modulates the selectivity of the second GT domain, thereby ensuring alternating incorporation of GA and GlcNAc. Following glycosyl transfer, the nascent HA retains a UDP moiety bound at the second GT domain. Concomitant to glycosyl transfer, the polymer moves into the TM channel by one sugar unit. Monomeric viral HAS elongates the non-reducing end of HA and the single GT domain binds UDP-activated substrates to trigger glycosyl transfer. Subsequently, UDP is released to allow binding of a new substrate molecule.
only UDP-GA can follow -GlcNAc and vice versa. Detailed biochemical and structural analyses are required to delineate the mechanistic details of HA translocation.
Materials and methods
Cloning of HAS expression constructs
Hyaluronan synthase (HAS) from S. equisimilis D181 (Se) or Paramecium bursaria chlorella virus (Cv) was PCR amplified from genomic DNA and cloned with a C-terminal hexa-His tag into the pET28a vector (Novagen) using NcoI and XhoI restriction sites. For co-expression of C-terminally His-and FLAG-tagged Se-HAS, the gene was cloned into the pETDuet vector (Novagen) with the His-tagged copy at the first (NcoI/BamHI) and the double FLAG-tagged copy at the second (NdeI/KpnI) multiple cloning site (MCS). Similarly, Cv-HAS was cloned with an N-terminal His-tag into MCS1 of pACYCDuet-1 (Novagen) using the BamHI and NotI restriction sites and with a C-terminal double FLAG-tag in MCS2 using the KpnI and EcoRV restriction sites. To co-express wild type and catalytically inactive HAS, one or both HAS genes were mutated using the QuikChange site directed mutagenesis kit (Stratagene). HAS-SNAP fusion constructs were made by cloning HAS genes into the pSNAP-tag (T7)−2 vector (New England Biolabs). Cv-HAS was cloned using the NcoI and EcoRV restriction sites, producing a construct with a C-terminal His-and SNAP-tag. Se-HAS with a C-terminal His-tag was cloned into the BamHI and NotI restriction sites, producing a construct with an N-terminal SNAP-tag. QuikChange mutagenesis was used to introduce site-specific amber mutations into the FLAG-tagged Se-HAS expression vector.
The cDNA encoding HAS1 from X. laevis was obtained from GE Dharmacon (IMAGE clone ID: 4889432) . The open reading frame was amplified by PCR and inserted into the transfer vector pFastBac (Invitrogen) which has been modified for ligation independent cloning (LIC) and which adds an in-frame N-terminal polyhistidine tag for purification (pFB-LIC-Bse). pFB-LIC-Bse was a generous gift from Opher Gileadi (Addgene plasmid # 26108). The identity of the resulting construct was verified by DNA sequencing.
Generation of bacmids and production of baculovirus were as described (Kalathur et al. 2016) . Briefly, bacmids were prepared by transforming the recombination strain DH10-Bac with the transfer vector containing the X. laevis HAS1 open reading frame and plating cells on LB agar containing antibiotics and Bluo-Gal (goldbio. com). Non-recombinant and recombinant bacmids were distinguished by blue/white color selection, respectively. Bacmid DNA was isolated by alkaline lysis and alcohol precipitation. Recombinant bacmids were confirmed by PCR amplification across the insert, using vector-specific oligonucleotide primers.
Protein expression and purification
Se-and Cv-HAS were expressed in E. coli C43, which was grown to an OD 600 of 0.6, and protein expression was induced with 0.5 mM isopropyl-ß-D-thiogalactoside (IPTG) at 30°C. The cells were harvested 14 h after induction, resuspended in 25 mM MES pH 6.5, 300 mM NaCl, 5 mM ß-mercaptoethanol, 20 mM imidazole pH 6.5, and 10% glycerol (RB-buffer), and lysed in a microfluidizer. Aggregated material was removed by centrifugation for 20 min at 19,000 ×g in a Beckman JA-20 rotor. Inverted membrane vesicles (IMVs) were isolated by flotation on a 1.8 M sucrose cushion and centrifugation for 2 h in a Beckman 45-Ti rotor at 200,000 ×g. The membrane fraction on top of the cushion was diluted 5-fold in RBbuffer and sedimented by centrifugation for 2 h at 200,000 ×g in a 45-Ti rotor (Beckman). The membrane pellet was homogenized in 1 mL of RB-buffer per liter of cells and stored in aliquots at −80°C. For protein purification following cell lysis, the membrane fraction was sedimented at 200,000 ×g in a 45-Ti rotor for 90 min at 4°C and was solubilized for 1 h at 4°C in RB-buffer containing 1 mM phenylmethylsulfonyl-fluoride (PMSF) and 2% (v/v) Triton X-100 for Se-HAS or 30 mM dodecyl-β-D-maltopyranoside (DDM, Anatrace) for Cv-HAS. After pelleting the detergent-insoluble material for 30 min at 200,000 ×g, the supernatant was incubated with 1 mL Ni-NTA agarose (Qiagen) per 2 L of cells for 1 h at 4°C. The column was washed with 100 mL RB-buffer containing 1 mM LysoFosCholine Ether-14 (LFCE14, Anatrace) (W-buffer). The protein was eluted in 10 mL 20 mM Tris pH 7.5, 100 mM NaCl, 5 mM ß-mercaptoethanol, 400 mM imidazole, 10% glycerol, and 1 mM LFCE14 (EB-buffer), concentrated to 500 μL, and loaded onto an analytical Superdex S200 gel filtration column (GE Healthcare) equilibrated in EB-buffer lacking imidazole and containing 5 mM DTT instead of ß-mercaptoethanol. Fractions were combined, concentrated to 300 μM as determined by UV absorbance using an extinction coefficient at 280 nm of 65,780 M cm −1 for Se-HAS or 23,500 M cm −1 for Cv-HAS and reconstituted into proteoliposomes.
Buffers used for Cv-HAS purification contained 0.05% (w/v) Lauryl Maltose Neopentyl Glycol (LMNG) and 0.01% (w/v) cholesteryl hemisuccinate (Anatrace) instead of LFCE14 and 20 mM MES pH 6.5 instead of Tris buffer. Para-benzoylphenylalanine (Bpa) was introduced into Se-HAS amber mutants using the amber codon suppressor technique by coexpressing with the suppressor tRNA and tRNA/aminoacyl-tRNA synthetase (encoded on a pACYC derived plasmid) in the presence of Bpa (Ryu and Schultz 2006) . C43 E. coli cells were co-transformed with the amber suppressor and Se-HAS containing plasmids and grown in LB at 37°C at 220 rpm to OD 600 = 0.6-0.8 in the presence of 50 and 25 μg/mL of kanamycin and chloramphenicol, respectively. Protein expression was induced at 25°C with 0.1 g/L IPTG and 54 mg/L of Bpa, followed by incubation overnight. Bpa-dependent expression of the mutant proteins was assessed by western blotting (anti-FLAG) of whole cell extracts using negative control cultures in which Bpa was excluded.
Bpa-containing Se-HAS mutants were purified using ANTI-FLAG M2 Affinity Gel (Sigma-Aldrich) based on the manufacturer's recommendations. Membranes were solubilized with 2% (v/v) Triton X-100 in 50 mL/1-L cell pellet of buffer (150 mM NaCl, 25 mM Tris pH 7.5, 2 mM DTT, 1 mM PMSF: Buffer 1) for 1 h with rocking at 4°C. For affinity purification, the membrane extract was incubated with 250 μl of ANTI-FLAG M2 Affinity Gel for 1 h, then resin was pelleted and resuspended in a total volume of 3 mL Buffer 1 containing 1 mM LFCE14 and 0.3 mg/mL E. coli total lipid extract. This pelleting and washing was repeated three times. The bound protein was eluted in the presence of 100 μg/mL 3xFLAG Peptide (Sigma-Aldrich) and directly reconstituted into proteoliposomes (see "Protein Reconstitution").
For Xl-HAS expression, the generated bacmid was used for transfection of Sf9 cells and baculovirus-containing media was collected 5 days later. The virus was amplified by using the harvested media to infect Sf9 cells a second time, with media harvested after 3 days. This was repeated a third time to produce the final high-titer virus stock. For protein expression, Sf9 cells were infected with recombinant baculovirus at a multiplicity of infection of three and cells were harvested by centrifugation after 2-4 days. IMVs were prepared from the harvested cells in 25 mM Tris pH 7.5, 100 mM NaCl, 5 mM DTT and 20% glycerol and treated with benzonase to degrade contaminating DNA. Aliquotted IMVs were flash-frozen in liquid nitrogen and stored at −80°C.
Purified Pm-HAS (residues 1-703) was a kind gift from Paul DeAngelis. Pm-HAS was diluted to a final concentration of 0.2 mg/mL in 25 mM Tris pH 7.2, 1 M ethylene glycol in the absence of cations, aliquoted and flash-frozen for storage at −80°C.
Labeling of HAS-SNAP fusion proteins
SNAP-HAS fusion constructs were purified as described above for Se-HAS. Upon binding of the His-tagged proteins to Ni NTA-agarose, the resin was washed with 70 mL W-buffer and the resin was resuspended in 5 mL of W-buffer. SNAP-Surface AlexaFluor647 substrate (New England Biolabs) was added to 30 μM and allowed to react for 20 h at 4°C with agitation. The resin was then washed with 35 mL of W-buffer and the protein eluted as described above. Gel filtration chromatography was used to remove any remaining substrate, yielding protein that was 97-99% specifically labeled as determined by UV absorbance using extinction coefficients at 280 and 647 nm of 86,750 and 270,000 M cm 
Protein reconstitution
For proteoliposomes (PLs) used in standard activity assays, 1 mg of dried E. coli total lipid extract (Avanti Polar Lipids) was solubilized in 250 μL 25 mM MES pH 6.5, 100 mM NaCl, 10% glycerol, 1 mM DTT, and 20 mM LFCE14 and purified HAS was added to a final concentration of 3 μM. The detergent was removed by stepwise addition of SM-2 Biobeads (BioRad) at 4°C until turbidity indicated the formation of lipid vesicles. The PLs were aliquoted and stored at −80°C. For use in chemical cross-linking or supported lipid bilayer TIRF experiments, 1 mg 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) or E. coli total lipid extract (Avanti Polar Lipids) was solubilized in 1 mL 20 mM octyl-glucoside (Anatrace) and protein was added to 1:10 6 -10 8 protein to lipid molar ratio. Detergent was removed by overnight dialysis against 2 L of Buffer D (25 mM MES pH 6.5, 100 mM NaCl, 5 mM MgCl 2 , 5 mM MnCl 2 , 1 mM DTT). If substrate was included during reconstitution, 0.002 mM UDP-GA was added to Buffer D. Single and dual wavelength TIRF experiments were conducted using E. coli total lipid extract and DOPC PLs, respectively. In vitro HA synthesis and translocation was performed as described previously (Hubbard et al. 2012) . Purified Bpa-containing Se-HAS mutants were combined with E. coli total lipid extract solubilized in 40 mM LFCE14 to a final lipid/ detergent concentration of 4.0 mg/mL lipid, 5 mg/mL LFCE-14 (approximately 1 mL total volume) and reconstituted upon addition of SM-2 Biobeads; 50 μl aliquots were flash-frozen for storage at −80°C.
Detergent solubilization of HAS IMVs
IMVs were formed as described above; 10 μL IMVs were solubilized in Buffer RB with 40 mM lauryl-N,N-dimethylamine N-oxide, 20 mM sodium cholate, 20 mM DDM, 1 mM LFCE14, 10% w/v Triton X-100 or 2% w/v digitonin for 1 h at 4°C. Insoluble material was removed by centrifugation for 15 min at 200,000 ×g at 4°C and the soluble material was used for in vitro HA biosynthesis. For "rereconstitutions", the detergent was removed from the membrane extract by stepwise addition of SM-2 BioBeads at 4°C until turbidity indicated the formation of lipid vesicles.
Co-purification of HAS
IMVs were combined with Buffer A (25 mM MES pH 6.5, 100 mM NaCl, 10% glycerol, 2 mM β-mercaptoethanol, 2% w/v digitonin, and 20 mM MgCl 2 for Se-or MnCl 2 for Cv-HAS) at a 1:10 vol/vol ratio. IMVs were solubilized at 4°C for 1 h with agitation. Insoluble material was removed by centrifugation at 14,000 ×g for 20 min at 4°C and the supernatant was applied to Ni-NTA agarose or Anti-FLAG M2 Affinity Gel. Samples were incubated at 4°C for 1 h with rotation and the resin was sedimented by centrifugation at 2500 ×g for 5 min at 4°C. The resin was washed 3 times with Buffer A containing 0.2% digitonin. Complexes were eluted using 200 mM imidazole pH 6.5 or 0.5 mg/mL 3xFLAG Peptide in Buffer A containing 0.2% digitonin. Samples were immediately used for activity assays. For tandem purification, the first eluted fraction was used for the second round of purification.
Chemical cross-linking
Ten microliter DOPC PLs were combined with 10 μL Buffer B (25 mM MES pH 6.5, 200 mM NaCl, 5 mM MgCl 2 , 5 mM MnCl 2 , 1 mM UDP-GA). Glutaraldehyde (Sigma-Aldrich) was added to 1-10 mM and the samples were incubated for 0.5-20 min at room temperature. Cross-linking was stopped with 200 mM Tris pH 7 followed by incubation for 20 min prior to reducing SDS-PAGE.
Site-specific cross-linking of Se-HAS
Initial validation and optimization of the Bpa photo-crosslinking protocol was performed in whole cell extracts of a single Bpa mutant of glutathione S-transferase (GST), derived from pGEX-6p, carrying Bpa at position 51 (F51BPA). Cross-linking of the GST protomers occurred after 7-10 min of exposure to long-wave UV light (data not shown).
For Se-HAS Bpa cross-linking, mutant or WT Se-HAScontaining IMVs were exposed to long-wave UV light on wet ice for at least 10 min. Samples were then solubilized in 2% (w/v) SDS/ 25 mM N-ethylmaleimide (NEM) and incubated in the dark for 10 min. Reducing (Laemmli) buffer was added to 1×. The total volume was then doubled with addition of an equivalent volume of 8 M urea, 2% SDS. Samples were then resolved in 12.5% SDS-PAGE gels, transferred to nitrocellulose membranes, and blotted for FLAG-tagged proteins. Bpa mutants exhibiting UV-dependent dimerization in IMVs were expressed, purified and reconstituted into PLs (see above). UV-induced cross-linking in PLs was performed as described above for IMVs.
In vitro HA biosynthesis
HA synthesis protocols were optimized for each HAS species tested. Synthesis with Se-HAS or Xl-HAS was performed in 20 mM MgCl 2 , 75 mM NaCl, 40 mM Na 2 HPO 4 pH 7.5, and 5 mM DTT; Cv-HAS used 20 mM MnCl 2 , 75 mM NaCl, 40 mM Tris pH 8, 5 mM DTT; and Pm-HAS required 20 mM MnCl 2 , 25 mM Tris pH 7.2, and 1 M ethylene glycol and addition of HA oligosaccharide primers generated by enzymatic digestion of bovine HA (Sigma) followed by phenol-chloroform extraction for protein removal. All reactions were run for at least 30 min and up to 4 h at 30°C with 5 mM UDP-GA and -GlcNAc in the presence of either 0.2 μCi UDP- H-labeled HA was quantified by descending paper chromatography as described (Hubbard et al. 2012) . Hyaluronidase digestion was performed as described (Hubbard et al. 2012) . Activity data are presented in disintegrations per minute (DPM) and are not normalized to the concentration of expressed or purified HAS. Thus, DPM readings vary depending on enzyme concentration, ranging from~µg/mL (Figure 1 ) to~ng/mL (Figure 2) . Samples containing 14 C-labeled HA were mixed with reducing gel loading buffer containing 2% Triton X-100 instead of SDS and run into 15% polyacrylamide Tris-borate-EDTA (TBE) gels in TBE buffer, pH 8.3 at 300 V for 25 min. The gels were soaked in 3% glycerol and 30% methanol for 20 min, dried under vacuum at 80°C, and exposed to a BioMax film (GE Healthcare) for 1-7 days at −80°C.
UDP-labeling of HA
14 C-UDP-GA was generated from 14 C-UDP-glucose by incubation with recombinant E. coli UDP-glucose dehydrogenase (UGD). UGD was expressed and purified as described (Mainprize et al. 2013 ). 14 C-UDP-glucose (PerkinElmer) was dried under vacuum and dissolved in reaction buffer containing 100 mM glycine pH 9.5, 100 mM NaCl, 10% glycerol. Conversion to UDP-GA was catalyzed by UGD in the presence of 1 mM NAD, 1 mM ATP, 1 mM pyruvate, 9 U of lactate dehydrogenase, and 0.5 mg/mL UGD for 60 min at RT. The reaction mixture was aliquoted, stored at −80°C and used directly as a source of 14 C-UDP-GA. Control reactions in the presence of UDP-GA and -GlcNAc as well as UDP-14 C-glucose confirmed that UDP-glucose is not incorporated into the HA polymer (data not shown). HA labeling reactions were performed as described previously (Hubbard et al. 2012) , with the exception that tracer was not added from the beginning. Unlabeled HA was synthesized for 10-45 min in the presence of 1 mM of each substrate at 30°C, followed by addition of 14 C-UDP-GA or UDP-14 C-GA. The labeled HA was then analyzed by PAGE and autoradiography as described above.
Single-molecule photobleaching
Supported planar bilayers with reconstituted HAS-SNAP fusion protein were prepared by a combined Langmuir-Blodgett/vesicle fusion technique as previously described (Kalb et al. 1992) . Quartz slides were cleaned by boiling in Contrad detergent for 10 min and then bath sonicated while still in detergent for 10 minutes followed by extensive rinsing with MilliQ water. Immediately before use, the slides were placed for 1 min in an argon plasma sterilizer (Harrick Scientific, Ossining, NY). To prepare the first layer of the supported bilayer the Langmuir-Blodgett transfer technique was used. A monolayer of chloroform-solubilized E. coli total lipid extract (Avanti) was placed onto the water surface in a Nima 611 LangmuirBlodgett trough (Nima, Conventry, UK). The solvent was allowed to evaporate for 10 min, before the monolayer was compressed at a rate of 10 cm 2 /min to reach a surface pressure of 32 mN/m. After equilibration for 5-10 min, a clean quartz slide was rapidly (200 mm/min) dipped into the trough and slowly (5 mm/min) withdrawn, while a constant surface pressure was maintained. The slides were stored under desiccation until use within 12 h. The top layer of the supported bilayer was formed with PLs containing AlexaFluor647-labeled HAS. The quartz slides with the first leaflet of the bilayer were placed in a holding chamber and 100 μL PL solution with 1.2 mL Buffer D was added until the holding cell was completely filled. Chambers were incubated at RT for 1 h. Excess vesicles were removed by perfusion with 10 mL of Buffer D.
To initiate HA synthesis, the PL solution was incubated with 1 mM UDP-GA and 1 mM UDP-GlcNAc for 20 min at RT. Experiments were carried out on a Zeiss Axiovert 200 fluorescence microscope (Carl Zeiss, Thornwood, NY), equipped with a 63× water immersion objective (Zeiss; N.A.0.95) and a prism-based total internal reflection fluorescence (TIRF) illumination system. The beams of the 514 nm line of an argon ion laser (Innova 90 C, Coherent, Palo Alto, CA), controlled through an acousto-optic modulator (Isomet, Springfield, VA), and a diode laser (Cube 640, Coherent) emitting light at 640 nm were directed (72°from the normal) into a prism above the quartz slide to illuminate the sample by total internal reflection at the quartz/water interface with a characteristic penetration depth of~102 and~130 nm for the 514 and 647 nm lasers, respectively. Alexa647 was excited at 640 nm and the fluorescence was observed through a dichroic mirror (660dclp, Chroma, Brattleboro, VT) and a long-pass filter (HQ665lp, Chroma). Alexa546 was excited at 514 nm and the fluorescence was observed through a dichroic mirror (565dclp, Chroma) and a band-pass filter (D605/55, Chroma). The prism-quartz interface was lubricated with glycerol to allow easy translocation of the sample cell on the microscope stage. Fluorescence signals were recorded by an electron-multiplying charge-coupled device camera (EMCCD, iXon DV887ESC-BV, Andor, Belfast, UK). The laser intensities, light-blocking shutters, and cameras were controlled by a homemade program written in LabVIEW (National Instruments, Austin, TX). Single-molecule images were taken in frame-transfer mode every 50 ms for up to 75 s.
To detect the presence of a nascent HA polymer in HAScontaining bilayers, HA synthesis was initiated in PLs before fusion with the bilayer. After the initial incubation and perfusion, a 1 μg/mL biotinylated bovine hyaluronan binding protein (HABP, Sigma-Aldrich) solution in Buffer D with 1% (w/v) BSA was added to the supported bilayer holding chamber and incubated for 30 min at RT. The chamber was then washed with 20 mL of Buffer D with 1% BSA. To detect the presence of HABP, 1.2 mL of 1.6 μg/mL AlexaFluor546-conjugated streptavidin (New England Biolabs) in Buffer D with 1% BSA was added to the holding chamber. After perfusion with 10 mL of Buffer D with 1% BSA, the chamber was immediately imaged. Without moving the chamber, the light source was switched to detect AlexaFluor647-labeled HAS in the same location and images were taken every 50 ms. To confirm that the AlexaFluor546 signal was specific to the presence of HABP and thus HA, a solution of 20 u/μL sheep testicular hyaluronidase (Sigma-Aldrich) in Buffer D was added to a holding chamber with a bilayer containing synthetically active HAS pretreated with HABP and streptavidin.
Single-molecule photobleaching analysis
Particles were identified using an adapted and previously described single particle tracking algorithm (Kiessling et al. 2006; Domanska et al. 2009 ). The peak and mean fluorescence intensities of a 5 × 5 pixel region of interest around each identified particle were plotted as a function of time through a set of 250-300 images. Traces were manually analyzed and particles that exhibited exponential bleaching indicating protein aggregation were discarded, which were no more than 5-10% of the total particles analyzed. The number and intensity of bleaching steps for each trace were manually recorded. The drop in intensity for each bleaching step was consistent for all particles analyzed and served as an additional control to distinguish between single and overlapping bleaching steps. Additionally, aggregated and exponentially bleaching particles exhibited a significantly (5×) higher initial intensity, allowing easy detection of "outliers". Each experiment represents at least two separate protein preparations and at least four separate supported planar bilayers prepared.
Dual color experiments relied on the exact overlay of images taken to detect AlexaFluor546-labeled HA with those recording AlexaFluor647-labeled HAS. Each set of images were overlaid by pinpointing at least four artifacts (aggregation with high intensity), which appeared in both images; these points were used to create a matrix to spatially rotate and translate both images to perfectly overlay ( Figure S4B ). The position of each region of interest representing a fluorescent HAS was then traced to the spatially corresponding region of interest representing AlexaFluor546-labeled HA.
Supplementary data
Supplementary data is available at GLYCOBIOLOGY online.
